disrupted interaction among various brain regions. As human brain regulates various systems of human body, its dysfunction could lead to multiple symptoms found in schizophrenia. These include but not limited to auditory hallucinations and deficiency in speech and language processing. Since auditory hallucinations, speech and language are related to hearing, it is reasonably acceptable that auditory related functions were affected in patients with schizophrenia. Moreover, as auditory hallucinations are common symptoms in schizophrenia, investigating auditory processing system in the affected patients is important. Perhaps this could, in general, clarify our understanding on the mechanism of schizophrenia.
INTRODUCTION
mentioned, speech-auditory processing deficits are associated with the psychiatric illness. Hence, due to the dominant functions of left brain on speech-auditory processing, speculating left brain abnormalities in patients with schizophrenia is logical. The presence of verbal auditory hallucination (VAH); i.e., hearing voices without their external presence; strengthens the assumption. Interestingly, the speculation is supported by abnormal findings on neuroimaging studies related to the left lobe functional [10] [11] [12] [13] and anatomical structures. [14] [15] [16] [17] In addition, abnormal findings in patients with schizophrenia during dichotic listening test also suggest left temporal lobe abnormality. An active competition, within the lobe, between auditory hallucination and externally delivered sounds led to reduction in their right ear advantage. 18 Nevertheless, these findings focused on the higher auditory center. As auditory processing also involves subcortical regions, the investigation should include these regions as well.
Findings on auditory processing deficits involving subcortical regions have added valuable information in schizophrenia. For instance, increased lateral asymmetry, 19 anomalies in auditory brainstem response (ABR) 20, 21 and middle latency response (MLR) 22 have been documented. These abnormalities strengthen the idea of auditory processing deficits in the population. However, these studies observed the bottom-up processing of auditory stimuli. In other words, the objectives focused on the ability of afferent auditory pathway to process the incoming auditory signals. In reality, our auditory system is not simply a "one-way traffic" that carries auditory stimuli from bottom to higher auditory centers, particularly the auditory cortex. The fact is efferent or "top-down" auditory pathways do exist in humans. 23, 24 These pathways play significant roles in regulating peripheral auditory system, including the outer hair cells of the cochlear. [24] [25] [26] Together with afferent pathway, they form multiple feedback loops to modulate the function of auditory system. 27 Hence, investigation on efferent pathway should receive equal priority.
The complex structures and physiological functions of humans' efferent auditory pathway have not been thoroughly explored. The current beliefs are, at this point, the pathway alters the micro mechanics of cochlear outer hair cells (OHCs). The beliefs are supported anatomically with the presence of medial olivocochlear (MOC) and cortico-olivocochlear bundles which are found at brainstem and higher auditory centers respectively. 19 The MOC projects its myelinated fibers from the medial superior olivary complex (SOC) before it terminates at the base of contralateral cochlear OHCs. [23] [24] [25] Similarly, the existence of cortico-olivocochlear pathway in humans was also reported, which enables the modulation of cochlear micro-mechanisms via auditory cortex. 18, 19 For instance, selective auditory attention which activates primary and secondary auditory cortex has been postulated to affect OHCs mechanisms. 21, 26 Interestingly, the amplitude of otoacoustic emissions (OAE) was reduced if auditory cortices were electrically stimulated. 24 In addition, together with afferent system, the corticofugal system helps in modulating multiple feedback loops of auditory system. 27, 28 Hence, by exploring the function of efferent pathway could assist us in explaining the mechanisms of auditory processing in patients with schizophrenia.
The investigation on the medial olivocochlear (MOC) pathway in patients with schizophrenia was pioneered by Veulleit et al. 29 Since then, limited reports have been published on the efferent auditory pathway of the clinical population. They reported that patients with schizophrenia showed absence of contralateral suppression asymmetry which reflects the absence of the right ear advantage (REA). In contrast, normal healthy controls showed higher contralateral suppression on the right ear. They concluded that the absence of lateral asymmetry in schizophrenia patients MOC system may lead to central lateralization anomalies.
The contralateral suppression of transient evoked otoacoustic emissions (TEOAE) is a clinical procedure to quantify the magnitude of OHCs suppression. 30 It permits an indirect, noninvasive, evaluation of MOC (efferent) functions. The procedure requires the amplitude of TEOAEs to be recorded separately in the absence and presence of contralateral noise. [31] [32] [33] In an intact auditory pathway, the presence of contralateral noise reduces the amplitude of TEOAE in the ear which it is being recorded. The contralateral suppression was defined as a positive difference in TEAOE amplitude between quiet and noise. 34, 35 An intact efferent pathway should contribute to at least 1 dB SPL of contralateral suppression. 36 Hence, by using contralateral suppression, we are indirectly assessing the intactness of efferent auditory fibers.
The current, case-control, study aims to investigate the efferent auditory pathway of patients with schizophrenia, by using a non-invasive contralateral suppression of linear TEOAE. The main research question is whether deficits in efferent auditory pathway exist in patients with schizophrenia. This is important due to empirical evidences that support the existence of auditory processing deficits in the group. As a matter of fact, the afferent and efferent auditory pathways form a multi-level auditory feedback loops in human's auditory system. The existence of the loop systems further complicates our understanding in auditory processing deficits among patients with schizophrenia. As in the afferent fibers, contributions from efferent pathway in schizophrenia are yet to be explored. Perhaps, the investigation of efferent auditory pathway would update the current knowledge and understanding on auditory processing among schizophrenia patients.
METHODS

Participants
The current case-control study involved a total of 39 randomly selected right handed subjects who written consent was obtained prior to audiological assessments. Ethical approval was obtained from Universiti Kebangsaan Malaysia Medical Centre (UKMMC) ethics committee. Subjects, in order to be included, must have normal hearing, clinically stable with Brief Psychotic Rating Scales (BPRS) less than 31 37 and able to cooperate for assessments. On the other hand, subjects with extrapyramidal symptoms, neurological disorders and severe psychotic conditions were excluded. Out of the total subjects, 16 (10 males; 6 females) were schizophrenia patients aged between 19-44 years old (mean: 32.51, SD=6.93) recruited from psychiatry clinic Universiti Kebangsaan Malaysia Medical Centre (UKMMC). The diagnosis of schizophrenia was confirmed following the DSM-IV, while the validated Malay version of Psychotic Symptom Rating Scales (MyPSYRATS) was used to determine the severity of psychosis. The MyPSYR-ATS had shown good internal consistency (r=0.85) and interrater agreement (ICC=0.877, 95% CI=0.336-0.941). 38 At the time of assessment, all patients were currently on the second generation antipsychotics. 23 healthy subjects aged between 22-36 years old (mean=27.48, SD=3.98) were chosen as controls (10 males; 13 females).
Audiological procedures
All subjects underwent a two-stage assessment procedure which was carried out in a, 40±2 dBA ambient noise level, 18'×12' sound proof room. First, basic audiometric tests with aims to assess hearing and middle ear status were conducted. In order to reach the goals, a Grason-Stadler GSI-61 clinical audiometer plugged with TDH-50P headphones, was used to separately measure air conduction hearing thresholds in both ears. The thresholds, determined by applying modified Hughson-Westlake procedure, were obtained at each octave frequency between 250 Hz and 8000 Hz. All subjects were fully cooperated and demonstrated good test-retest reliability. Normal hearing was defined as thresholds at 20 dB HL or better across all frequencies tested.
In order to examine subjects' middle ear status, a standard clinical procedure for acoustic immittance measures was conducted by using a Grason-Stadler GSI Tympstar middle ear analyzer. The procedure consists of tympanometry and acoustic reflexes. Initially, a 226 Hz probe tone tympanometry was conducted with pump speed at 200 daPa/sec and air pressure from +200 to -400 daPa. A normal Type A tympanogram was characterized as a sharp amplitude peak centered in between ±50 daPa. Subsequently, ipsilateral and contralateral acoustic reflexes with pulsing tone at 500 Hz, 1000 Hz and 2000 Hz with initial intensity at 75 dB HL were delivered to determine the reflex thresholds. Reflex thresholds were determined by varying the intensity level in 5-dB increments until the threshold was detected. The thresholds for acoustic reflexes were defined as the lowest level of pulsing tone needed to elicit at least a 0.02 mmhos deflection in middle ear admittance. The presence of Type A tympanogram and normal level of acoustic reflexes (≤95 dB HL) defines normal middle ear function.
In the second stage, outer hair cells (OHCs) cochlear function and suppression were tested with an Otodynamics analyzer (Otodynamics, Echoport ILO 288) and ILOV6 software package. The apparatus were used to generate test stimuli and record TEOAE responses. Initially, non-linear click stimulus at 80 dBpe SPL was delivered to determine the functionality of cochlear outer hair cells in both ears. Robust otoacoustic emissions with at least 3 dB above noise floor suggest healthy outer hair cells cochlear function. The TEOAE recordings were terminated at 260 sweeps and accepted when the TEO-AE responses and stimulus stability was at least 60% and 80% respectively. Later, the contralateral suppression procedure took place. It involved two consecutive steps; i.e., initially during the absence and later followed by a simultaneously presented 65 dB HL white noise on the contralateral (non-test) ear. The same audiometer delivered the white noise via 3A insert phone to the contralateral ear during OAE measurement on the test ear. In both conditions, absence and presence of noise, 60 dBpe SPL linear clicks were delivered to the test ear. TEOAE was recorded in right and left ear for each subject, where the ear site for test and non-test condition was randomly determined. Two recordings were obtained on each ear for every condition. A one minute break was applied before a second TEOAE measurement was recorded on the same ear. The same steps were then repeated on the non-test ear. The TEO-AE amplitude difference between in quiet and in noise was calculated. The positive difference, between quiet and noise, in the TEOAE amplitudes indicates the presence of TEOAEs suppression.
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Statistical analysis
Analysis was performed using SPSS 21. All data are presented in mean and standard error. In regard to suppression value, the interaction effect between group, gender and ears and main effects were analyzed with a three way mixed ANOVA. The TEOAE amplitude at 80 dB SPL, separated by diagnosis group, was analyzed using a two way mixed ANOVA. In addition, independent samples t-test was also conducted to compare the mean between ears.
RESULTS
Absolute TEOAE amplitude at 80 dBpe SPL The mean TEOAE amplitudes, for right and left ear, were compared between normal and schizophrenia patients. Independent samples t-test showed no significant difference in right ear mean TEOAE amplitude between normal and schizophrenia patients (p>0.05). Similarly, the difference in left ear TEOAE amplitude between the groups was also not significant (p>0.05). (Table 2 ).
Contralateral suppression
DISCUSSION
The current study, in general, compares the mean contralateral suppression between patients with schizophrenia and healthy controls. The suppression value obtained from normal subjects in the present study is in agreement with previous studies. 39, 40 The composite, right and left ear, contralateral suppression revealed a statistically significant difference between the two diagnostic groups. Surprisingly, instead of reportedly similar MOC function between healthy controls and schizophrenia patients, 29 the present study found significantly higher Patients with schizophrenia have been associated with abnormal γ-aminobutyric acid (GABA) system function. 41, 42 GABA, a neurotransmitter produced in humans' brain, functions to regulate the release of acetylcholine (Ach) at the presynaptic end of efferent auditory neurons. GABA does this by activating its pre-synaptic GABABRs which inhibits the release of ACh from olivocochlear bundle terminals. 43 In fact, during the stimulation of the fibers; these two major neurotransmitters have been found at the pre-synaptic neurons. Once released, ACh attaches at α9α10 Ach receptors located at the base of OHCs. The activation of these receptors permits the influx of Ca 2+ ions into the OHCs. Subsequently, as the concentration of these ions increase in the cells, this leads to opening of SK2 K + channels. Opening of the Ca 2+ dependent SK2 K + channels allows the efflux of K + from the OHCs and finally causes hyperpolarization of OHCs. 44 Hyperpolarization of OHCs subsequently reduces the motility of the cells leading to reduction of OAE amplitude. With regard to the present study, the reduced GABA production in patients with schizophrenia would result in over release of acetylcholine. The over production of Ach in these patients would then lead to hypersensitivity of OHCs micro-mechanisms. Consequently, the hyper-excitation of efferent neurons increases hyperpolarization of OHCs thus leads to larger suppressions.
Since the statistical analysis revealed no significant difference between left and right data in both groups, further considerations should be highlighted. As illustrated in Figure 1 , even though the mean TEOAE suppression levels in left and right ears were not statistically different, the value is descriptively higher in the right side among the schizophrenia group. Perhaps by increasing the sample size, more significant outcomes will be obtained. The asymmetry issues among schizophrenia subjects have been investigated. 45, 46 This might approve the contribution of left temporal lobe anomalies as reported in previous studies. For instance, failure in corollary discharge that fails to suppress the activities of left auditory cortex 47 could lead to stimulation of efferent pathway. In fact, temporal lobe are abnormally active especially during hallucinations. 48 Thus, we speculate that the abnormal discharge of left temporal lobe would stimulate the neurophysiological function of efferent auditory pathway which, lead to the alteration of OHC mechanisms. In addition, stimulating the left auditory cortex of schizophrenia patients with contralateral acoustic stimulation (CAS) might further enhance the activities of efferent pathway which finally influences OHC mechanisms. As a matter of fact, inducing efferent MOC with CAS reduces the amplitude of OAE 49 which is reflected as increase in suppression value. Nevertheless, the effects of auditory hallucinations on MOC and/or OHC mechanisms require further investigations.
Our current outcomes are in contrast with Veuillet and colleagues findings. 29 The later, except for differences in laterality, observed no statistically significant difference between healthy controls and schizophrenia groups. They reported that larger suppression in the right ear of healthy controls, as compared to left ear, was not evidenced in the schizophrenia patients. In other words, the pattern of asymmetry in suppression was absence in the latter group. Hence, they speculated that the absence of laterality in schizophrenia patients reflect the lack of right ear advantage (REA). In addition, unlike the healthy controls, the schizophrenia patients showed significantly higher absolute OAE amplitude in the right ear compared to the left ear. They concluded that these could be contributed by more central lateralization anomalies.
The differences in methods applied by Veuillet et al. 29 and our study could lead to the major discrepancies in outcomes. The former applied 5 levels of linear TEOAE clicks, increased in 3 dB steps, from 60 to 72 dB SPL. The contralateral broad band noise, used as CAS, was delivered consistently at 30 dB SPL. The level was 30 to 42 dB softer than the presented clicks, which could lead to insufficient suppression effect. In contrast, recent studies on contralateral OAE suppression have consistently applied CAS at least at the same levels of clicks presented to the ipsilateral ear. 50, 51 In our study, CAS was applied at 65 dB HL, which is still below the acoustic reflex thresholds for normal hearing person. The level is suitable to avoid the contraction of stapedial muscle. The exact reasons why GABA concentration level is reduced in patients with schizophrenia are unclear. Many possible reasons have been discussed including neurodevelopmental and the use of antipsychotic medications. 52 The level was found higher in schizophrenia patients taking typical compared to atypical antipsychotics. 53 In another study, which came out with two suggestions, a 6-month intake of atypical antipsychotics by early stage, first episode patients revealed no effect on GABA concentration level. 54 The study suggested that the treatment either had no effect on GABAergic transmission or it prevented the level from further reduction. As such, the two studies mentioned imply that atypical antipsychotics would probably maintain GABA concentration at low level, hence maintaining the hyperactivity of efferent system. In addition, based on an animal study, the medication was also found to increase the release of cortical ACh 55 which may also result in an increase in the suppression value.
Inability to attend towards external speech during an event of auditory hallucinations, a question which was raised to our patients, is one of the phenomenological features limitedly documented in schizophrenia studies. Majority of our patients reported lack of focus towards external sounds which could be simply due to their deficits in attention. Nevertheless, our study suggests an additional factor that might contribute to the feature. The increase in OHCs hyperpolarization during the activation of efferent fibers by the abnormal discharge of auditory cortex would facilitate the condition. The mechanism causes and creates reduction in OHCs motility and "stiffness" in the basilar membrane respectively. As a consequence, in response to external stimuli, lesser electrical signals are transmitted to higher auditory center. Even though this might not be the main contributor, the mechanism however could co-exist during the event of active hallucination. In contrast to the "normal suppression" in healthy controls that helps in enhancing speech perception in background noise, an abnormally larger suppression in schizophrenia could cause insensitive basilar membrane towards incoming signals, particularly speech sounds. Interestingly, as evidenced in our preliminary data on hearing in noise test (HINT), patients with schizophrenia require higher reception thresholds in speech compared to healthy controls during all noise conditions (data not shown). However, further investigations on cochlear mechanisms are required to explain the link between larger suppression and lack of attention towards external speech.
While performing the research, we acknowledged several limitations. Firstly, the present study did not determine the possible influence of gender on TEOAE suppression levels in the tested patients. Since the GABA production is influenced by gender difference, 56 comparing the TEOAE suppressive effect between male and female patients would provide more information regarding the mechanism of the efferent system. Secondly, only the averaged TEOAE values were analyzed and frequency-specific information was not gathered. If a similar study to be expanded in future, perhaps the TEOAE suppression test could be performed on subjects of different gender and the TEOAE outcomes at specific frequencies should be computed and analyzed.
In conclusion, the larger contralateral suppression found in patients with schizophrenia suggests the hyperactivity and neurophysiological deficits of their efferent auditory pathway. The larger right ear suppression in the patients group might support abnormal discharge of their left auditory cortex.
